Todd Pettingill
Corporate Officer/Principal chez OMNIAB, INC.
Postes actifs de Todd Pettingill
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| OMNIAB, INC. | Corporate Officer/Principal | - | - |
OmniAb Operations, Inc.
 OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | Corporate Officer/Principal | - | - |
Historique de carrière de Todd Pettingill
Anciens postes connus de Todd Pettingill
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Investor Relations Contact | - | - |
| Public Communications Contact | - | - |
Formation de Todd Pettingill
| Brigham Young University | Undergraduate Degree |
| UCLA Anderson School of Management | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| OMNIAB, INC. | Commercial Services |
| Entreprise privées | 1 |
|---|---|
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | Health Technology |
- Bourse
- Insiders
- Todd Pettingill
- Expérience
